On Invalid Date, Applied Therapeutics (NASDAQ: APLT) reported Q1 2023 earnings per share (EPS) of -$0.18, up 79.55% year over year. Total Applied Therapeutics earnings for the quarter were -$10.14 million. In the same quarter last year, Applied Therapeutics's earnings per share (EPS) was -$0.88.
As of Q2 2023, Applied Therapeutics's earnings has grown year over year. Applied Therapeutics's earnings in the past year totalled -$69.52 million.
What was APLT's revenue last quarter?
On Invalid Date, Applied Therapeutics (NASDAQ: APLT) reported Q1 2023 revenue of $10.66 million up Infinity% year over year. In the same quarter last year, Applied Therapeutics's revenue was $0.00.
What was APLT's revenue growth in the past year?
As of Q2 2023, Applied Therapeutics's revenue has grown null year over year. Applied Therapeutics's revenue in the past year totalled $10.66 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.